AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

AIDS Weekly articles from July 2004

15,821 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from AIDS Weekly are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for AIDS Weekly arrive.

AIDS Weekly archives from July 2004

New strategies detect HIV earlier and more effectively than ever.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Researchers at the Institute of Human Virology (IHV) have developed an ultra-sensitive testing technique that has shown the ability to detect HIV infection earlier than all current methods. This new...

International study will evaluate neurological disease in HIV/AIDS patients.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Researchers at the University of North Carolina (UNC) at Chapel Hill are preparing to launch an international clinical trial studying neurological disease in people with HIV and AIDS that is believed to...

HIV viral load rebounders have limited long-term naive CD4+ cell reconstitution.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- HIV viral load rebound patients have limited long-term naive CD4+ cell reconstitution. According to a study from Greece, "Long-term (3.5 years) immune reconstitution in relation to viral load...

Bis-anthracycline antibiotics inhibit HIV-1 transcription.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Bis-anthracycline antibiotics inhibit HIV-1 transcription. According to recent research published in the journal Antimicrobial Agents and Chemotherapy, "The increasing numbers of human...

WHO removes two drugs from list of approved HIV medicines.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The U.N. health agency has removed two Indian-made versions of antiretroviral drugs from its list of HIV medicines for use in developing countries over concerns that pharmaceutical company Cipla may...

Uganda begins distributing free generic AIDS drugs.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Uganda has begun distributing free generic HIV drugs in a program aimed at treating all of the country's estimated 100,000 people living with AIDS. The distribution makes Uganda only the second...

DDR1/DDR2 potential role in obstructive diseases of blood vessels and lungs.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Discoidin domain receptors 1 and 2 have potential roles in obstructive diseases of the blood vessels and lungs. According to a study from the United States, "Obstructive diseases of blood vessels...

''Collateral damage'' linked to cephalosporin or quinolone antibiotic therapy.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- ''Collateral damage'' is linked to cephalosporin or quinolone antibiotic therapy. "Collateral damage'' is a term used to refer to ecological adverse effects of antibiotic therapy; namely, the...

Antiviral proteins from C. album L leaves inhibit virus infections.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Antiviral proteins from Chenopodium album L leaves inhibit virus infections. According to published research from India, "Antiviral proteins (AVPs) named CAP-I and CAP-II purified from the leaves of...

Patients with chronic ulcers and erosions should be screened for MRSA.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Patients with chronic ulcers and erosions should be screened for MRSA. According to a study from Germany, "The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) was prospectively...

Results of AVR118 phase I/II clinical program presented at ASCO.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company presented interim results of its phase I/II clinical program with its flagship product, AVR118, at The American Society of Clinical...

Different levels of adherence determine specific antiretroviral resistance.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Different levels of adherence determine specific antiretroviral resistance. According to a study from the United States, "Public health debates about providing HIV antiretroviral therapy to...

Mexican females at higher risk for HIV infection than males.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- More likely than Mexican males to have unprotected sex, young Mexican females put themselves at a higher risk for HIV infection. According to research published recently in the journal AIDS...

FDA issues warning letter regarding Norvir.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories has received a warning letter from the U.S. Food and Drug Administration's Division of Drug Marketing Advertising and Communications (DDMAC) outlining concerns related to the website...

Advocacy group applauds G8 inclusion of AIDS vaccine as agenda item.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The International AIDS Vaccine Initiative (IAVI) applauded the Group of Eight Industrialized Nations (G8) for including HIV/AIDS - and specifically a preventive vaccine - on the agenda for this year's...

Early diagnosis and treatment of primary HIV-1 infection may be critical.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Early diagnosis and treatment of primary HIV-1 infection may be critical. According to recent research published in the journal Clinical Infectious Diseases, "Emerging evidence suggests that early...

Fusion inhibitors effective in HIV patients able to maintain virological control.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Fusion inhibitors are effective in HIV patients that are able to maintain virological control. "The number of antiretroviral-experienced HIV patients with multiple resistances against the currently...

Investigational PI 640385 (VX-385) indicates activity against HIV.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) and Vertex Pharmaceuticals, Inc., (VRTX) presented data for an investigational protease inhibitor (PI) 640385 (VX-385) that appears to be active against HIV, including strains that...

Low-dose iron supplementation does not increase HIV-1 load.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Low-dose iron supplementation does not increase HIV-1 load. According to published research from Denmark, "Observational data suggest that iron may increase HIV replication and the rate of...

MQOL-HIV is valid for use with HIV-infected women.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The Multidimensional Quality of Life Questionnaire for Persons with HIV/AIDS (MQOL-HIV) is valid for use with HIV-infected women. According to a study from Canada, "Since the late 1980s, several...

Sleep deprivation protects against HIVgp120 and TNF-alpha deleterious effects.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Sleep deprivation protects against the HIVgp120 and TNF-alpha deleterious effects. According to recent research published in the journal Neuroscience Letters, "The human immunodeficiency virus (HIV)...

Kaposi sarcoma is a model for cancer immunotherapy.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Kaposi sarcoma is a model for cancer immunotherapy. For over a century physicians have "attempted to harness the potential therapeutic power of the immune system to treat patients with cancer. The...

Management strategy for anemia in HIV infection elucidated.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- A management strategy for anemia in HIV infection has been elucidated by consensus. According to a study from the United States, "Anemia in human immunodeficiency virus (HIV)-infected patients can...

United States House moves to help AIDS orphans in developing nations.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The United States House of Representatives has directed the government to increase its help for orphans and vulnerable children in developing countries and moved to set up a new office concentrating on...

Prevention interventions needed to elicit prevention myths in active drug users.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Prevention interventions are needed to elicit prevention myths in active drug users. "Drug injectors and crack users (526) in South Florida responded to a survey questionnaire that was designed to...

Denial of AIDS puts sailors and partners at risk.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- AIDS is now the leading cause of death in military and police forces in some African countries, accounting for more than half of inservice mortality, according to Ugboga Nwokoji and Ademola Ajuwon. ...

Efforts to prevent mother-to-child transmission require both parents.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- A Tanzanian woman's acceptance of voluntary counseling and HIV testing depends on her perceived value of it to her child, as well as support from her male partner, researchers report. According to...

Experts: Integrate AIDS prevention and treatment to fight epidemic.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Mistakes made by industrialized nations in dealing with the AIDS epidemic could be repeated in developing countries unless HIV prevention efforts are expanded along with treatment, experts warn. In...

Limited response to PMTC transmission program in Zimbabwe.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Zimbabwe's efforts to prevent the transmission of HIV from mothers to their children is being undermined by a limited response to the initiative, the head of the program, Agnes Mahomva, told a national...

HAART-PI but not HAART-NNRTI strongly inhibit SAP expression in the oral cavity.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Highly active anti-retroviral therapies with protease inhibitors but not non-nucleoside reverse-transcriptase inhibitors strongly inhibit SAP expression in the oral cavity. "Highly active...

HIV-1 long terminal repeat repressed by the c-Myc oncoprotein.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The HIV-1 long terminal repeat is repressed by the c-Myc oncoprotein. "The effect of trans-acting factors on cis-acting DNA elements on the HIV-1 promoter are the principal determinant regulating...

HIV-related germ cell tumor not more aggressive than GCT in general population.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- HIV-related germ cell tumor is not more aggressive than GCT in the general population. "Testicular germ cell tumor (GCT) is not an AIDS-defining illness despite an increased incidence in men with...

KSHV-encoded LANA protein stabilizes beta-catenin by binding to GSK-3.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Kapsosi sarcoma-associated herpesvirus-encoded LANA protein stabilizes beta-catenin by binding to the negative regulator GSK-3. "The Kapsosi's sarcoma-associated herpesvirus, KSHV, is associated...

Novel polysulfated galactose-derivatized dendrimers binding antagonists of HIV-1.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Novel polysulfated galactose-derivatized dendrimers are binding antagonists of HIV-1. According to recent research from the United States, "Evidence indicates that galactosyl ceramide (GalCer) and...

OTK18 expression in brain NIP parallels severity of HIV-1 encephalitis.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. "OTK18 was isolated by mRNA differential display of human monocyte-derived macrophages (MDM) infected...

Anal Pap smears inaccurate predictor of high-grade anal dysplasia.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Anal Pap smears are inaccurate predictors of high-grade anal dysplasia. "We compared the pathological diagnoses obtained by anal Papanicolaou (Pap) smear with those obtained by anal biopsy or by...

Increased HIV testing in underutilized venues may increase HIV status awareness.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Increased HIV testing in underutilized venues may increase the awareness of HIV status. According to recent research from the United States, "In an effort to help fight the HIV epidemic, we offered...

Indiana awards 38 grants to test minorities for HIV.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- About one in four people with HIV does not know it, so everyone at risk of contracting it, particularly among blacks, should get tested and receive counseling, Indiana health officials say. HIV...

Measure of barriers to HIV testing among high-risk individuals developed.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- A measure of barriers to HIV testing among high-risk individuals has been developed. "Rates of HIV antibody testing remain at approximately 45% of the general population. To more effectively design...

CCR5 antagonists may be effective as anti-HIV-1 agents.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- CCR5 antagonists may be effective as anti-HIV-1 agents. "We have previously reported the novel lead compound 1a as a CCR5 antagonist for treatment of HIV-1 infection," wrote researchers in Japan....

CD4+ T-cell response increased with sustained virologic control following HAART.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- CD4+ T-cell response is increased in HIV-infected patients with sustained virologic control following HAART. According to recent research published in the Journal of Acquired Immune Deficiency...

Maintenance therapy discontinuation for histoplasmosis safe after HAART response.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Discontinuing maintenance therapy for disseminated histoplasmosis is safe after HIV-infected patients respond to antiretroviral therapy. "We performed a prospective observational study to assess the...

New HIV-1 integrase inhibitors developed.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- New HIV-1 integrase inhibitors have been developed. "Existing AIDS therapies are out of reach for most HIV-infected people in developing countries and, where available, they are limited by their...

New data on Remune suggests HIV-1 specific immune responses.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The Immune Response Corporation (IMNR) announced that research results presented at the International Symposium on HIV & Emerging Infectious Diseases in Toulon, France, suggest that its lead product...

PL-100 HIV protease inhibitor profile presented at international workshop.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Procyon Biopharma Inc. (PBP) presented a scientific poster reporting on the favorable resistance profile of the company's proprietary HIV protease inhibitor, PL-100, at the XIIIth International HIV Drug...

Pharmacokinetics of indinavir plus low-dose ritonavir in children similar.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The pharmacokinetics of indinavir plus low-dose ritonavir in HIV-1-infected children studied. According to a study from Netherlands, "So far, no pediatric doses for indinavir combined with ritonavir...

Piperazine-based CCR5 antagonists effective against HIV-1.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Piperazine-based CCR5 antagonists are effective against HIV-1. According to published research from the United States, "The nature and the size of the benzylic substituent are shown to be the key...

TAMs accumulate at similar rates during ZDV or d4T treatment.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Thymidine analogue resistance mutations accumulate at similar rates during ZDV or d4T treatment. "Zidovudine (ZDV) and stavudine (d4T) select for the same set of thymidine analogue resistance...

rAAV technology highlighted for its potential utility in AIDS prevention.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) announced that its recombinant adeno-associated viral (rAAV) vector technology was highlighted for its potential utility in the prevention of AIDS at the 7th Annual...

Medications help keep AIDS victims alive.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Kerry Morrow is 38 years old, but feels 98. HIV-positive since 1986 and diagnosed with AIDS in 1998, Morrow can't work, can't drive and can't clean his own house. He shuffles around his living...

Sterile needle program eyed in Atlantic City, New Jersey.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Defying a state ban, city officials are poised to approve New Jersey's first needle exchange program for intravenous drug users in hopes of stemming what one health official calls an "epidemic" of HIV...

Drugs given away by AIDS patients in U.S. prolong lives worldwide.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Jose Clemente, who restores artworks in Mexico's capital, has never met Daphne Rivera, a Brooklyn health educator. But medicines donated by Rivera are keeping Clemente alive. From Mexico to...

Hepatitis E virus in human feces detected and quantitated by real-time PCR.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Hepatitis E virus in human feces was detected and quantitated by a real-time PCR assay. "Hepatitis E virus (HEV) is the causative agent of an acute and self-limited form of hepatitis. The virus is...

HBV/HIV coinfected patients increased risk for virologic failure after HAART.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- HBV/HIV coinfected patients have an increased risk for virologic failure after HAART. "Between June 1994 and February 2003, a total of 111 human immunodeficiency virus (HIV)-infected patients with...

Study: Filtration protects patients from pathogens in hospital water.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- As awareness of the dangers of hospital water rise with each new infectious outbreak, Janet Stout, PhD, director of special pathogens laboratory, Veterans Administration (VA) Pittsburgh (Pennsylvania)...

Octagam is efficacious for treating primary immunodeficiency diseases.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Octagam 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases. According to published research from the United States, "Octagam is an...

Alternative pathway complement activation critical in P. aeruginosa infection.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Complement activation by the alternative pathway is critical for survival of Pseudomonas aeruginosa infection. According to recent research published in the journal Infection and Immunity,...

Complement has role in pathogenesis of invasive fungal infections.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Complement has a role in the pathogenesis of invasive fungal infections. "New therapeutic approaches enable organ transplantations and guarantee longer survival for AIDS patients or patients with...

Complications with A. niger infection is characterized by a high mortality rate.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Hematological disease complicated by Aspergillus niger infection is characterized by a high mortality rate. According to recent research published in the journal Mycoses, "In this paper we analyzed...

Mechanism of fluconazole resistance in C. glabrata during prophylaxis elucidated.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The mechanism of fluconazole resistance in Candida glabrata during prophylaxis has been elucidated. "Candida glabrata can become resistant to fluconazole, causing persistent colonization and...

Hospital says flawed cleaning procedure may have exposed patients to viruses.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- A hospital notified 177 patients that they may have been exposed to HIV or hepatitis because equipment used to check their digestive systems might not have been properly cleaned. North Shore...

FDA accuses maker of antiretroviral of misleading promotions.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has accused Abbott Laboratories, Inc., of providing the public with misleading information about a drug used to treat HIV infection, saying the promotional...

Scottish study of deaths in drug injectors shows early help is critical.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Government and health care services are being urged to make special help available for young people who inject drugs, in a bid to minimize drug-related deaths. In a newly published study of causes...

La protein binds to NS5 and NS3 and to 5' and 3' ends of Dengue 4 virus RNA.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- La protein binds to NS5 and NS3 and to the 5' and 3' ends of Dengue 4 virus RNA. According to recent research published in the journal Virus Research, "In vitro replication of dengue virus requires...

Pure H20 Bio-Technologies announces new potable water disinfection systems.
July 5, 2004... 2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Pure H20 Bio-Technologies, Inc., (PHBT) announced the completion of its all-stainless steel medical and residential systems. Model 7000 is the company's premier medical system designed to assist...

Genomic selection strategy likely to define targets relevant for HIV-1 therapy.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- A developed genomic selection strategy is likely to define targets relevant for HIV-1 therapy. According to a study from Denmark, "Defining target sites for antisense oligonucleotides in highly...

HIV viral load of subtype C underestimated in assays optimized for subtype B.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- HIV viral loads from patients with subtype C are underestimated in assays that are optimized for subtype B. According to recent research from Israel, "Quantitation assays of HIV-1 RNA used...

Novel stavudine analog improved anti-HIV activity and decreased cytotoxicity.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- A novel stavudine analog has improved anti-HIV activity and decreased cytotoxicity. "The antiviral drug 2',3'-didehydro-3'-deoxythymidine (D4T; also know as stavudine and Zerit), which is used...

Simian restricting factor binding insufficiently mediates postentry HIV-1 block.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Simian restricting factor binding insufficiently mediates the postentry HIV-1 block. According to a study from the United States, "In cells of Old World and some New World monkeys, dominant factors...

Novel oral CCR5 antagonists are highly potent against HIV-1.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Novel oral CCR5 antagonists are highly potent against HIV-1. "The search for orally active CCR5 antagonists was performed by chemical modification of the, 1-benzothiepine 1,1-dioxide 3 and...

Recommendations for topical microbicides to prevent HIV updated.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission have been updated. "The development of methods to prevent HIV infection is critical to...

Pediatricians advised to be attentive to needs of gay, lesbian youth.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Approximately 5% of young people consider themselves lesbian, gay, or bisexual, and many adolescents know a friend, classmate, neighbor, or relative who is nonheterosexual. Pediatricians are being...

Programs in Malawi empower girls as approach to tackling HIV.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- In 2003, 19-year-old Mercy Msiskashe was forced to drop out of school because her family could not afford to pay the fees. "Some of my family members encouraged me to find a boyfriend and then get...

Reduced vancomycin susceptibility has emerged in successful epidemic lineages.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Reduced vancomycin susceptibility has emerged in successful epidemic lineages. According to a study from England, "Methicillin-resistant Staphylococcus aureus (MRSA) with reduced vancomycin...

MP-1 changes name to reflect company growth.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Phoenix Biosciences, Inc., focused on developing, testing, and offering affordable treatments for immune dysfunctions, with a concentration on HIV/AIDS, has officially changed its name from MP-1, Inc.,...

"Search and destroy" protein turns tables on HIV.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- A human protein that mutates the AIDS virus (HIV) and holds potential for keeping the disease at bay has been discovered and its function described by a team led by Reuben Harris of the University of...

Infection still associated with poor HIV/AIDS prognosis.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Results of a U.K. study highlight how the treatment of cytomegalovirus infection remains a priority to improve the prognosis for people with HIV-1 infection, including people already receiving...

Dopaminergic system implicated in the etiopathogenesis of HIV dementia.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- The dopaminergic system is implicated in the etiopathogenesis of HIV dementia. According to published research from Germany, "The basal ganglia, structures rich in the neurotransmitter dopamine,...

Novel gene (VanK) required for vancomycin resistance.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- A novel gene is (VanK) required for vancomycin resistance. According to recent research from England, "Vancomycin is the front-line therapy for treating problematic infections caused by...

Alpha,alpha-trehalose derivatives inhibit HIV-1 Tat-TAR RNA interaction.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Alpha,alpha-trehalose derivatives inhibit HIV-1 Tat-TAR RNA interaction. According to published research from China, "Replication of HIV-1 requires specific interactions of Tat protein with TAR...

Cyclooxygenase inhibitors improve T-cell proliferation in HIV-infected patients.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Cyclooxygenase inhibitors improve T-cell proliferation in HIV-infected patients on HAART. "Prostaglandin E[subscript]2 is synthesized via cyclooxygenases and induces cyclic adenosine 3',...

Muscle adiposity important determinant of hyperinsulinemia in HIV infection.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- Muscle adiposity is an important determinant of hyperinsulinemia in HIV infection. According to recent research published in the Journal of Clinical Endocrinology and Metabolism, "The...

Researchers report new ultra-sensitive AIDS test.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- A new AIDS test can detect HIV infection earlier than any current method, raising hopes not only for earlier diagnosis but for better treatment, researchers at the Institute of Human Virology (IHV)...

AIDS epidemic threatens decade-old sexual and reproductive health targets.
July 12, 2004... 2004 JUL 12 - (NewsRx.com & NewsRx.net) -- The global HIV/AIDS epidemic is threatening efforts to achieve sexual and reproductive health goals that are supposed to improve the lives of women and reduce poverty, the head of the United Nations...

More articles from AIDS Weekly: 1 | 2
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA